The increasing complexity of environmental pollution nowadays poses a severe threat to the public health, which attracts considerable attentions in searching for nanomaterials of multiproperty. In this study, mesoporous silica of KIT-6-encapsulated bismuth oxychloride (BiOCl), an intrinsically multifunctional material exhibiting bunched structure in the composites, are facilely prepared under hydrothermal conditions. Subsequently, the produced materials of multifunctionality were applied for photocatalysis, antibacterial test, and simultaneous determination of heavy metals including lead and cadmium. A combination of physiochemical characterizations have revealed that the BiOCl–KIT-6 composites exhibit enlarged yet refined surface morphology contributing to the improved photocatalytic ability with a band gap of 3.06 eV at a molecular ratio of 8Bi–Si. Moreover, the antibacterial activities of our BiOCl–KIT-6 composites were explored, and possible antimicrobial mechanism related to the production of reactive oxygen species was discussed. Furthermore, a sensitive electrochemical determination of heavy metals of lead and cadmium using square-wave anodic stripping voltammetry was also achieved. The composites-modified glassy carbon electrode displays a linear range of calibration curve from 0.2 to 300 μg/L with a detection limit of 0.05 μg/L (Pb2+) and 0.06 μg/L (Cd2+), respectively.

In recent decades, tremendous progress has been made in understanding serine/threonine protein phosphatase-dependent pathways, which are involved in the regulation of numerous processes, including secretion, cell motility, cell cycle, gene transcription, and cell metabolism (1-7). Serine/threonine phosphorylation, which is regulated by many kinases, can be reversed by a few phosphatases that are targeted to substrates via dozens of regulatory subunits (7,8). Currently, serine/threonine protein phosphatases (PPs) are grouped into two structurally distinct families: the PPP family (PP1, PP2A, and PP2B) and the PPM family (PP2C and pyruvate dehydrogenase phosphatase) (9). The PP2A heterotrimeric protein complex, which consists of a cascade of three subunits, namely, a catalytic subunit (C) and a structural subunit (A) associated with a third, hypothetically competitive and variable regulatory subunit (B), represents a highly conserved eukaryotic signal transduction system that is present in many organisms, from yeasts to humans. The activity of PP2A, along with its subcellular localization, is determined by B-family subunits (10-14). In mammals, PP2A is a major intracellular protein phosphatase that regulates multiple aspects of cell growth and metabolism (15). Therefore, PP2A is one of a few serine/threonine-specific phosphatases in the cell, and its complex structure and regulation system guarantee its various functions. The ability of this widely distributed heterotrimeric enzyme to function on a diverse array of substrates is largely controlled by the nature of its regulatory Bfamily subunits. Thus, multiple isoforms of the B-family regulatory subunit have been isolated from different organisms and grouped into three classes (B, B=, and BЉ) based on their structural similarities (16,17). The structural variations between these families support the hypothesis that the B-family regulatory subunit controls enzyme activity and specificity, such that different activities of PP2A and subcellular localization are determined by Bfamily regulatory subunits. However, one challenge we face is the potential for redundancy in the regulatory subunits' function of assigning PP2A function in mammals (18)(19)(20). Therefore, it is difficult to approach the function of PP2A globally by knocking out one of the regulatory subunits. In contrast, simple eukaryotic organisms, such as Saccharomyces cerevisiae (budding yeast) and Schizosaccharomyces pombe (fission yeast), which contain only a few isoforms of B-family regulatory subunits, are excellent model systems for studying how B-family regulatory subunits function in regulating PP2A activity. In fission yeast, there is only one B subunit of PP2A-Pab1 and two of the B=-encoding genes (par1 and par2) (21-24). Moreover, mutational studies in fission yeast have demonstrated that B regulatory subunits play crucial roles during the processes of cytokinesis, cell morphogenesis, and cell wall synthesis (25,26). Similarly, in budding yeast, studies have shown that the B class has only one ...

SummaryTimely cytokinesis/septation is essential for hyphal growth and conidiation in Aspergillus nidulans. Genetic analyses have identified that A. nidulans has components of the septum initiation network (SIN) pathway; one of these, SEPH, is a key player for early events during cytokinesis. However, little is known about how the SEPH kinase cascade is regulated by other components. Here, we demonstrate that the phosphoribosyl pyrophosphate synthetase family acts antagonistically against the SIN so that the downregulation of AnPRS family can bypass the requirements of the SIN for septum formation and conidiation. The transcription defect of the Anprs gene family accompanied with the reduction of AnPRS activity causes the formation of hyper-septation as well as the restoration of septation and conidiation in the absence of SEPH. Clearly, the timing and positioning of septation is related to AnPRS activity. Moreover, with the extensive yeast two-hybrid analysis and rescue combination experiments, it demonstrated that AnPRS members are able to form the heterodimers for functional interacting entities but they appear to contribute so unequally that Anprs1 mutant display relatively normal septation, but Anprs2 deletion is lethal. Thus, compared to in yeast, the AnPRS family may have a unique regulation mechanism during septation in filamentous fungi.

Antifungal treatment is often ineffectual, partly because of biofilm formation. In this study, by using a combined forward and reverse genetic strategy, we identified that nucleus-localized AfSsn3 and its partner AfSsn8, which constitute a Cdk8-cyclin pair, are required for azole resistance in Deletion of led to increased absorption and utilization of glucose and amino acids. Interestingly, absorption and utilization of glucose accelerated the extracellular polysaccharide formation, while utilization of the amino acids serine, threonine, and glycine increased sphingolipid pathway intermediate accumulation. In addition, the absence of induced the activity of the efflux pump proteins. These factors indicate the mature biofilm is responsible for the major mechanisms of resistance to azoles in the Δ mutant. Collectively, the loss of led to two "barrier" layers between the intracellular and extracellular spaces, which consequently decreased drug penetration into the cell.

Mono‐chemotherapy has significant side effects and unsatisfactory efficacy, limiting its clinical application. Therefore, a combination of multiple treatments is becoming more common in oncotherapy. Chemotherapy combined with the induction of ferroptosis is a potential new oncotherapy. Furthermore, polymeric nanoparticles (NPs) can improve the antitumor efficacy and decrease the toxicity of drugs. Herein, a polymeric NP, mPEG‐b‐PPLGFc@Dox, is synthesized to decrease the toxicity of doxorubicin (Dox) and enhance the efficacy of chemotherapy by combining it with the induction of ferroptosis. First, mPEG‐b‐PPLGFc@Dox is oxidized by endogenous H2O2 and releases Dox, which leads to an increase of H2O2 by breaking the redox balance. The Fe(II) group of ferrocene converts H2O2 into ·OH, inducing subsequent ferroptosis. Furthermore, glutathione peroxidase 4, a biomarker of ferroptosis, is suppressed and the lipid peroxidation level is elevated in cells incubated with mPEG‐b‐PPLGFc@Dox compared to those treated with Dox alone, indicating ferroptosis induction by mPEG‐b‐PPLGFc@Dox. In vivo, the antitumor efficacy of mPEG‐b‐PPLGFc@Dox is higher than that of free Dox. Moreover, the loss of body weight in mice treated mPEG‐b‐PPLGFc@Dox is lower than in those treated with free Dox, indicating that mPEG‐b‐PPLGFc@Dox is less toxic than free Dox. In conclusion, mPEG‐b‐PPLGFc@Dox not only has higher antitumor efficacy but it reduces the damage to normal tissue.